The pathophysiology, risk factors, and clinical management of fat embolism syndrome. A comprehensive review

Nº de DOI: 10.34896/RSI.2025.43.31.001

AUTHORS

1. Milipsa Stephanie Pozo Andrade. General Practitioner. Attached to the Armed Forces General Hospital. Graduate of the University of the Americas. (Quito-Ecuador). https://orcid.org/0009-0003-7863-0803
2. Carla Nicole Amores Sandoval. General Practitioner. Attached to Atlas Clinics. Graduated from the University of San Francisco in Quito. (Quito-Ecuador). https://orcid.org/0009-0005-6250-7207
3. Juan Carlos Serrano Alvarez. General Practitioner. Attached to Private Clinics in Ecuador. Graduate of the University of Guayaquil. (Guayaquil-Ecuador). https://orcid.org/0009-0008-5584-0142
4. Rodrigo Fernando Cabrera Jadán. General Practitioner and Master’s Degree in Occupational Health and Safety. Attached to Labovida Quito Headquarters. Graduate of the Technical University of Loja. (Quito-Ecuador). https://orcid.org/0009-0004-4641-6797
5. Bryan Alejandro Carlosama Moreno. General Practitioner. Attached to San Francisco General Hospital. Graduate of the Central University of Ecuador. (Quito-Ecuador). https://orcid.org/0009-0008-6698-8150

ABSTRACT

This comprehensive review aims to elucidate the intricate pathophysiology, identify key risk factors, and evaluate current clinical management strategies for FES, thereby providing a foundation for improved diagnosis, treatment, and prevention of this complex syndrome.

KEY WORDS

Fat embolism syndrome, fat embolism, long-bone fractures, orthopaedic trauma, pathophysiology, risk factors.

RESUMEN

Esta revisión integral tiene como objetivo dilucidar la compleja fisiopatología, identificar los principales factores de riesgo y evaluar las estrategias actuales de manejo clínico del SEG, proporcionando así una base para mejorar el diagnóstico, el tratamiento y la prevención de este síndrome complejo.

PALABRAS CLAVE

Síndrome de embolia grasa, embolia grasa, fracturas de huesos largos, trauma ortopédico, fisiopatología, factores de riesgo.

INTRODUCTION

Fat Embolism Syndrome (FES) is a complex and potentially life-threatening condition that arises when fat globules enter the systemic circulation, leading to a cascade of pathophysiological events that can cause multi-organ dysfunction. Although initially associated predominantly with traumatic events such as long bone fractures and orthopedic surgeries, FES can also occur in non-traumatic contexts, making its pathogenesis and risk profile multifaceted. The underlying mechanisms involve the liberation of fat globules from bone marrow or adipose tissue, which then embolize to vital organs like the lungs, brain, and skin, triggering inflammatory responses, vascular occlusion, and hemorrhage, as evidenced by characteristic histopathological findings such as fat globules within capillaries and alveolar spaces. The susceptibility to FES is influenced by various patient-specific factors, including age and underlying comorbidities, as well as procedural risks associated with trauma, surgical interventions, and fractures. Despite its clinical significance, early diagnosis remains challenging due to nonspecific symptoms, necessitating a thorough understanding of diagnostic strategies and supportive management approaches. Effective clinical management hinges on prompt recognition, supportive therapies—such as oxygen supplementation and hemodynamic stabilization—and preventative measures in high-risk populations to mitigate morbidity and mortality.

OBJECTIVE

Elucidate the complex pathophysiology, identify key risk factors, and evaluate current clinical treatment strategies for Fat Embolism Syndrome, thereby providing a basis for improving the diagnosis, treatment, and prevention of this complex syndrome.

METHODOLOGY

This article was designed as a comprehensive narrative review of the current evidence on the pathophysiology, risk factors, and clinical management of fat embolism syndrome (FES). A structured literature search was performed in PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar for English-language articles published between January 2000 and November 2025, using combinations of the following terms: “fat embolism syndrome”, “fat embolism”, “long-bone fracture”, “polytrauma”, “intramedullary nailing”, “non-traumatic fat embolism”, “pathophysiology”, “risk factors”, and “clinical management”.

Original research articles, systematic reviews, clinical guidelines, and high-quality narrative reviews that reported data on incidence, pathophysiology, risk factors, diagnosis, or treatment of Fat Embolism Syndrome in adult or paediatric populations were considered eligible. Case reports and small case series were included selectively when they provided relevant insight into atypical etiologies (e.g., liposuction, severe acute pancreatitis, sickle cell disease) or emerging diagnostic or therapeutic strategies. Studies not focused on FES, abstracts without full text, non–peer-reviewed documents, and articles not available in English were excluded. Reference lists of key articles and recent state-of-the-art reviews were manually screened to identify additional eligible publications.

RESULTS

Pathophysiology of Fat Embolism Syndrome:

What are the underlying mechanisms leading to fat embolism syndrome?:

Fat embolism syndrome (FES) emerges from a complex interplay of mechanical and biochemical events following the introduction of fat into the circulatory system, most commonly after traumatic injuries such as long bone fractures, but it can also arise in less severe trauma scenarios or even in the absence of a clear fracture¹. The initial mechanical theory posits that trauma disrupts adipose tissue and medullary bone, leading to the direct release of fat globules into the venous circulation, which can then travel to vital organs such as the lungs, brain, and heart, causing vascular occlusion and subsequent tissue ischemia^1,2. However, this explanation falls short in accounting for the variable incidence of FES among patients with similar injuries and the observation that fat embolism can occur without manifesting as clinical syndrome². Consequently, biochemical mechanisms have been proposed, where trauma-induced hormonal and inflammatory responses trigger the release of free fatty acids and other bioactive lipid metabolites, which in turn exert toxic effects on vascular endothelium and promote a systemic inflammatory response, predisposing to organ dysfunction². Despite advances in experimental and clinical research, these mechanisms remain incompletely understood, and the pathogenesis of FES is recognized as multifactorial, with ongoing studies seeking to elucidate the precise molecular and cellular pathways involved². Given this uncertainty, a multidisciplinary approach to early recognition and intervention is essential to mitigate organ damage and improve patient outcomes.

How do fat globules enter the circulation and affect organ systems?:

Once fat globules enter the circulation, typically as a result of trauma-induced adipose tissue disruption or inadvertent vascular injection during procedures, they may travel as either intact adipocytes or as liquid triglycerides released from destroyed fat cells³. These fat globules can enter the bloodstream through several anatomical routes, such as via direct access to arterial branches or through retrograde flow generated by high-pressure injections, which can force fat material into small arteries against the natural blood pressure gradient³. Once in the circulatory system, fat emboli can reach vital organs—including the lungs, brain, and eyes—by traveling through both the venous and arterial systems, leading to a spectrum of complications that underscore the interconnection between vascular entry points and systemic organ impact^3,4. In the lungs, fat emboli frequently cause microvascular obstruction, which manifests clinically as respiratory distress, while cerebral embolization may result in neurological disturbances, and embolization of the retinal arteries can precipitate sudden blindness^3,4. The pathogenic process involves both mechanical and biochemical mechanisms: initial vessel occlusion by fat globules (mechanical obstruction), followed by hydrolysis of triglycerides into free fatty acids (FFAs), which exert toxic effects on endothelial cells and provoke inflammatory responses, thereby contributing to organ dysfunction and the clinical features of FES³. The widespread systemic effects resulting from fat embolism highlight the importance of cautious technique during fat injection procedures, early recognition of symptoms, and prompt intervention to mitigate the risk of irreversible organ damage.

What are the histopathological findings associated with fat embolism syndrome?:

Histopathological examination of lung tissue in fat embolism syndrome (FES) reveals several characteristic findings that help distinguish it from other causes of acute lung injury. The most notable observation is the significant accumulation of fat-laden macrophages within the alveolar spaces, which is much more pronounced in FES patients compared to trauma patients without FES, non-trauma patients with pulmonary infiltrates, and normal controls². These macrophages can be detected using specific stains such as Oil Red O in bronchoalveolar lavage (BAL) samples, enhancing the diagnostic accuracy for FES by directly visualizing the intracellular fat content². Furthermore, the level of intraalveolar cholesterol is markedly higher in FES cases than in other forms of acute lung injury or in healthy controls, highlighting a metabolic consequence of fat embolization that may contribute to the inflammatory and pathological cascade observed in the syndrome². The interplay between fat emboli, macrophage activation, and subsequent tissue response underscores the importance of integrating histopathological assessment with clinical and radiological findings for accurate diagnosis. Given these interconnections, it is crucial for clinicians and pathologists to be aware of the distinct histopathological markers of FES to guide management and implement timely interventions.

Risk Factors Associated with Fat Embolism Syndrome:

Which traumatic and non-traumatic events increase the risk of fat embolism syndrome?:

Fat embolism syndrome (FES) is most commonly precipitated by traumatic events, with particular emphasis on severe skeletal injuries such as long bone and pelvic fractures, which are recognized as the primary contributors to the risk of developing FES^2,5. The interconnection between orthopedic trauma and the syndrome is underscored by the high incidence of fat emboli observed following such injuries, studies suggest that up to 90 percent of individuals with severe skeletal trauma may experience fat embolism, highlighting the pathophysiological importance of bone marrow disruption and subsequent fat globule release into the systemic circulation^5,6. While orthopedic surgeries—including total hip arthroplasty—further amplify this risk due to direct bone manipulation, other traumatic events such as multiple fractures and soft tissue injuries, though less frequently, can also contribute to FES development, creating a complex domain where both severity and multiplicity of trauma play significant roles⁵. Non-traumatic events, although less common, should not be overlooked, clinical scenarios such as sepsis, liposuction, lipid infusion during parenteral feeding, pancreatitis, and even cardiopulmonary resuscitation have been implicated in the pathogenesis of FES, indicating that disturbances in fat metabolism and systemic inflammatory responses may act independently or synergistically with mechanical trauma^5,6. This intricate network of risk factors demonstrates the need for heightened clinical awareness and multidisciplinary interventions—early identification of at-risk patients, rapid stabilization of fractures, and vigilant monitoring—particularly in polytrauma and critical care settings, to mitigate the morbidity and mortality associated with fat embolism syndrome⁶.

What role do surgical procedures and fractures play in the development of fat embolism syndrome?:

The interplay between surgical procedures and fractures is central to the development of fat embolism syndrome (FES), particularly in trauma patients where the risk is substantially heightened by the severity and anatomical location of bone injury. Fractures, especially those involving long bones such as the femur or the pelvis, are well-documented as major precipitating factors for FES, with incidence rates climbing to 5%–10% in cases of multiple or pelvic fractures and 0.5%–2% in isolated long bone fractures⁷. Mechanistically, these fractures can release fat emboli into the bloodstream, a process that is further exacerbated during orthopedic surgical interventions, every manipulation or fixation of a long bone fracture presents an opportunity for fat and marrow elements to enter the circulatory system, making each surgical procedure a potential trigger for embolic complications⁸. Once released, fat emboli can cause mechanical obstruction in critical vascular territories such as the lungs and brain, leading to the classic clinical manifestations of FES⁸. Beyond physical blockage, both the initial fracture and subsequent surgical manipulation can trigger biochemical pathways, including the release of free fatty acids that damage the endothelium, compounding the risk of vascular compromise and systemic inflammation⁸. The interconnectedness of these domains—orthopedic trauma, surgical management, and systemic embolic risk—underscores the importance of careful fracture stabilization and surgical technique to minimize further embolic burden and reduce the risk of FES development⁹. Consequently, prompt and meticulous management of fractures, especially those of the pelvis and long bones, remains a cornerstone intervention to thwart the cascade of events leading to fat embolism syndrome in vulnerable patients.

Which supportive therapies are most effective in managing symptoms?:

In managing the diverse and sometimes severe symptoms associated with Fat Embolism Syndrome (FES), a multifaceted approach to supportive therapy has proven to be most effective. Supportive therapies play a critical role by fostering engagement with the patient’s broader support systems, which can alleviate feelings of isolation and promote emotional resilience during recovery¹⁰. Beyond social engagement, these therapies also assist patients in coping with external stresses that often accompany acute medical conditions like FES, thereby helping to reduce anxiety and improve overall well-being¹⁰. Furthermore, supportive therapy can facilitate the development of a coherent narrative about the patient’s condition, enabling individuals to make sense of their experiences and enhancing their capacity to tolerate and process complex emotions¹⁰. However, it is important to note that while supportive therapy provides indispensable psychosocial benefits, the integration of other modalities—such as exposure and response prevention (ERP) therapy and serotonin reuptake inhibitor (SRI) medications—may be necessary for optimal symptom management, especially when psychological distress is profound¹¹. Consequently, a combination of supportive and targeted interventions should be prioritized to achieve comprehensive care, underscoring the need for individualized treatment planning and ongoing assessment of patient needs.

How do various treatment strategies influence patient prognosis in FES cases?:

Given the complex pathophysiology and multisystem involvement in fat embolism syndrome (FES), the influence of various treatment strategies on patient prognosis requires a multifaceted approach that integrates both supportive and interventional measures. Supportive care forms the cornerstone of FES management, addressing respiratory compromise, hemodynamic instability, and neurological manifestations through interventions such as oxygenation, mechanical ventilation, and fluid resuscitation, all of which are essential in stabilizing patients and reducing morbidity^12,13. Early recognition and initiation of supportive therapy have been shown to improve outcomes by mitigating the progression of clinical manifestations and facilitating timely surgical interventions^12,13. The interconnection between prompt medical stabilization and surgical management is particularly significant, effective supportive care allows for early operative immobilization of fractures, ideally within 12 to 24 hours post-injury, which has been linked to a marked reduction in both the incidence and severity of FES as well as overall hospital stay and pulmonary complications¹². Furthermore, the choice of surgical technique—such as the use of less disruptive fixation methods (e.g., unreamed nails, plate osteosynthesis)—is intended to minimize further marrow disruption and prevent additional embolic events, although current evidence does not demonstrate significant differences in respiratory outcomes between certain techniques¹³. In cases with severe neurological impairment, the integration of neurocritical strategies—such as intracranial pressure (ICP) monitoring and antiepileptic therapy—can further influence prognosis by enabling rapid intervention for secondary brain injury¹³. Despite the lack of a universally accepted cure, these interconnected strategies underscore the importance of coordinated, multidisciplinary care, emphasizing the need for ongoing research and larger studies to refine treatment protocols and optimize long-term outcomes for patients with FES^12,13. Ultimately, the evidence highlights that prompt recognition, aggressive supportive therapy, and timely surgical intervention are all crucial actions needed to improve prognosis and reduce the burden of complications associated with FES.

What complications or sequelae are commonly observed following FES?:

Beyond the acute clinical presentation, fat embolism syndrome (FES) is notorious for causing a spectrum of complications and long-term sequelae that span multiple organ systems, reflecting the underlying pathophysiological insult of fat emboli obstructing microvasculature and triggering inflammatory cascades¹⁴. Respiratory complications are among the most prevalent, with patients frequently developing hypoxemia or acute respiratory distress syndrome (ARDS) due to fat globules lodging in pulmonary capillaries and inciting local inflammation, which can progress to pulmonary infarction and persistent functional impairment¹⁴. Neurologically, FES may precipitate cerebral infarctions and diffuse brain injury through similar vascular occlusive mechanisms, compounded by vasogenic edema and microhemorrhages that further compromise neural tissue and may result in cognitive or motor deficits¹⁴. Cardiovascular sequelae, though less commonly highlighted, can involve arrhythmias or hemodynamic instability secondary to myocardial embolization or systemic inflammatory responses, while dermatological manifestations such as petechial rashes serve as markers of underlying capillary damage¹⁴. The potential for multi-organ involvement, including renal or retinal infarctions, underscores the systemic nature of FES and the risk of chronic morbidity stemming from organ dysfunction or infarction following acute events¹⁴. These interrelated complications demonstrate the need for vigilant monitoring and early, multidisciplinary intervention to mitigate both immediate threats and longer-term sequelae in patients at risk for or diagnosed with FES.

DISCUSSION

The comprehensive review of Fat Embolism Syndrome (FES) elucidates the multifaceted nature of its pathophysiology, emphasizing the interplay between mechanical and biochemical mechanisms. The mechanical theory convincingly accounts for the immediate vascular occlusion caused by fat globules originating from traumatic injuries, particularly long bones and pelvic fractures, however, it falls short in explaining the variability in clinical presentation and incidents where fat embolism occurs without manifesting as full-blown FES. The incorporation of biochemical mechanisms provides a broader understanding of how trauma-induced hormonal and inflammatory responses exacerbate endothelial damage and systemic inflammation, thereby contributing to multisystem organ dysfunction. These findings underscore the importance of early stabilization of fractures and meticulous surgical techniques to minimize fat entry into circulation, which aligns with current clinical best practices. Nonetheless, the review highlights several limitations, including the reliance on histopathological and radiological markers that may lack specificity, and the variability in diagnostic criteria across studies, which can impede early diagnosis and consistent management. Furthermore, patient-specific factors such as age, comorbidities, and systemic inflammatory responses significantly influence susceptibility and outcomes, indicating a need for personalized approaches to prevention and treatment. Future research should focus on developing more sensitive diagnostic tools, exploring targeted therapies to mitigate biochemical toxicity, and establishing standardized protocols for early detection and intervention. Additionally, understanding the socio-cultural and community-based strategies for prevention, particularly in high-risk populations, represents an important avenue for reducing the incidence and morbidity associated with FES. Overall, this review advances our understanding of FES but also highlights gaps that warrant further investigation to optimize patient care and outcomes in this complex syndrome.

CONCLUSIONS

1. Fat embolism syndrome remains an uncommon but potentially life-threatening complication, most frequently associated with orthopaedic trauma involving long-bone or pelvic fractures, but also recognised in a range of non-traumatic settings such as severe acute pancreatitis, liposuction, lipid infusion, and haematologic or hepatic disease. Contemporary evidence supports a multifactorial pathophysiology in which mechanical obstruction by marrow fat globules, biochemical injury mediated by free fatty acids, and systemic inflammatory and coagulation responses act synergistically to produce the characteristic triad of respiratory distress, neurological impairment, and petechial rash.
2. Across the literature, the most consistent risk factors for FES include multiple or bilateral long-bone fractures, high-energy trauma, delayed fracture fixation, intramedullary instrumentation with elevated canal pressures, and reduced cardiopulmonary reserve, additional non-traumatic triggers broaden the spectrum of at-risk patients. Despite advances in imaging and critical care, diagnosis remains largely clinical, often guided by scoring systems such as those proposed by Gurd and Wilson or Schonfeld, and is complicated by the absence of specific biomarkers. Early recognition and aggressive supportive management—optimising oxygenation, ventilation, and haemodynamic stability—continue to be the cornerstone of care, while early, judicious stabilization of fractures appears to lower the incidence and severity of FES.
3. Pharmacologic strategies, particularly corticosteroids, show promising but still inconclusive evidence for prophylaxis or treatment, and no drug has yet achieved universal guideline endorsement. Overall, this review underscores that FES is both preventable and treatable when high-risk scenarios are anticipated, preventive orthopaedic strategies are implemented, and early clinical signs are promptly recognised. Future research should prioritise the development of standardized diagnostic criteria, validation of risk prediction tools, and robust trials evaluating targeted pharmacologic and surgical interventions, with the goal of further reducing morbidity and mortality associated with this complex syndrome.

REFERENCES

1. Emergency Care in Duchenne 2022 Annual Conference. Fat Embolism Syndrome [Internet]. Parent Project Muscular Dystrophy. 2018 [cited 2024 Nov 21]. Available from: https://www.parentprojectmd.org/care/care-guidelines/by-area/bone-and-joint-care/fat-embolism-syndrome/
2. Stump B, Weinhouse G. Fat Embolism Syndrome: Fact or Myth? Current Trauma Reports [Internet]. 2016 Apr 13 [cited 2020 May 14],2(2):66–72. Available from: https://doi.org/10.1007/s40719-016-0042-2
3. Kim H, Seo BF, Evans GRD. Fat embolism syndrome: a review in cosmetic surgery. Kosin Medical Journal [Internet]. 2024 Sep 30 [cited 2024 Oct 30],39(3):169–78. Available from: https://doi.org/10.7180/kmj.24.126
4. Brezic N, Gligorevic S, Atanasijevic T, Zivkovic V, Jovanovic B. Fatal fat embolism syndrome in a young trauma patient with a stable initial presentation: time to define predictive criteria? A case report. Journal of Trauma and Injury [Internet]. 2025 Apr 21 [cited 2024 Nov 21],1(1). Available from: https://doi.org/10.20408/jti.2024.0072
5. Maitre S. Causes, Clinical Manifestations, and Treatment of Fat Embolism. AMA Journal of Ethics [Internet]. 2006 Sep 1 [cited 2024 Nov 21],8(9):590–2. Available from: https://doi.org/10.1001/virtualmentor.2006.8.9.cprl1-0609
6. Wang W, Chen W, Zhang Y, Su Y, Wang Y. Post‐traumatic cerebral fat embolism syndrome with a favourable outcome: a case report. BMC Neurology [Internet]. 2021 Feb 18 [cited 2024 Nov 21],21(1). Available from: https://doi.org/10.1186/s12883-021-02076-0
7. Cleveland Clinic. Fat Embolism Syndrome [Internet]. Cleveland Clinic. 2022 [cited 2024 Nov 21]. Available from: https://my.clevelandclinic.org/health/diseases/23995-fat-embolism-syndrome
8. Gavrankapetanović I, Papović A, Jamakosmanović M, Baždar E, Tafro L. Fat Embolism in Orthopedic Surgery. Embolic Diseases – Unusual Therapies and Challenges [Internet]. 2017 Jun 21 [cited 2024 Nov 21],1(1). Available from: https://doi.org/10.5772/67710
9. American College of Surgeons. A Feared Complication of Long Bone Fracture: Fat Emboli in Transit [Internet]. ACS Case Reviews. 2024 [cited 2024 Nov 21]. Available from: https://www.facs.org/for-medical-professionals/news-publications/journals/case-reviews/issues/v5n4/13-roberson-fat-embolism-syndrome/
10. Welton RS, Crocker EM. Supportive Therapy in the Medically Ill. The Primary Care Companion For CNS Disorders [Internet]. 2021 Feb 18 [cited 2021 Jun 22],23(1). Available from: https://doi.org/10.4088/pcc.20nr02758
11. International OCD Foundation. OCD Treatment Guide: Best Evidence-Based Therapies, Medications, and New Advances [Internet]. International OCD Foundation. 2025 [cited 2024 Nov 21]. Available from: https://iocdf.org/ocd-treatment-guide/
12. The Consensus Research Library. Fat Embolism Syndrome: Symptoms, Types, Causes and Treatment [Internet]. The Consensus Research Library. 2025 [cited 2024 Nov 21]. Available from: https://topics.consensus.app/health/conditions/fat-embolism-syndrome-symptoms-types-causes-and-treatment
13. Jorgensen A, Bashir A, Satpathy J. Cerebral fat embolism syndrome (FES): similar cases with different outcomes. BMJ Case Reports [Internet]. 2018 Oct 8 [cited 2024 Nov 21],1(1):bcr-2018-225261. Available from: https://doi.org/10.1136/bcr-2018-225261
14. Yan X, Wu S, Zeng W, Kong J. Fat embolism syndrome caused by fracture or liposuction: a retrospective case series of nine patients. Annals of Medicine [Internet]. 2024 Dec 30 [cited 2024 Nov 21],57(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11703124/